14555244|t|The essentiality of Bcl-2, PKC and proteasome-ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti-Parkinson drug, rasagiline.
14555244|a|The anti-Parkinson drug, rasagiline, a irreversible propargyl possessing monoamine oxidase B inhibitor can protect neurons in vitro and in vivo from a variety of neurotoxic insults including SIN-1, glutamate, the parkinsonism inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, N-methyl-(R)-salsolinol and including beta amyloid protein. Recent studies have shown that rasagiline rapidly modulates intracellular signaling pathways involved in cell survival and death. Specifically rasagiline activates Bcl-2, Bcl-xl, protein kinase C (PKC) and reduces Bax in a variety of cells including PC-12 and neuroblastoma human dopamine derived SH-SY5Y cells. These enzymes play key roles in cellular events including modulation of apoptotic processes, neuronal plasticity and amyloid precursor protein processing. This pharmacological action of rasagiline is also associated with the prevention of the neurotoxin induced fall in mitochondrial membrane potential, opening of mitochondria permeability transition pore, activation of proteasome-ubiquitin complex, inhibition of cytochrome c release and prevention of caspase 3 activation, similar to the actions of cyclosporin A or Bcl-2 over expression in SH-SY5Y cells. Rasagiline and its various derivatives induces PKC dependent release of soluble amyloid precursor protein alpha and which is blocked by inhibitors of alpha-secretase, PKC and MAPK-dependent signaling. Structure-activity relationship with various propargyl containing derivatives of rasagiline including propargylamine itself has shown that the above described pharmacological action of these compounds resides in the propargylamine moiety. These results have provided a new understanding into the mechanism of neuroprotective actions of rasagiline and its anti-Alzheimer drug derivatives TV3326 and TV3279, which are relevant for therapy of Parkinson's disease, Alzheimer's disease and other neurodegenerative diseases.
14555244	20	25	Bcl-2	Gene	596
14555244	27	30	PKC	Gene	112476
14555244	132	146	Parkinson drug	Chemical	-
14555244	148	158	rasagiline	Chemical	MESH:C031967
14555244	169	183	Parkinson drug	Chemical	-
14555244	185	195	rasagiline	Chemical	MESH:C031967
14555244	212	221	propargyl	Chemical	-
14555244	233	252	monoamine oxidase B	Gene	4129
14555244	322	332	neurotoxic	Disease	MESH:D020258
14555244	351	356	SIN-1	CellLine	CVCL:TL19
14555244	358	367	glutamate	Chemical	MESH:D018698
14555244	373	385	parkinsonism	Disease	MESH:D010302
14555244	407	451	N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Chemical	MESH:D015632
14555244	453	476	N-methyl-(R)-salsolinol	Chemical	MESH:C032837
14555244	544	554	rasagiline	Chemical	MESH:C031967
14555244	656	666	rasagiline	Chemical	MESH:C031967
14555244	677	682	Bcl-2	Gene	596
14555244	684	690	Bcl-xl	Gene	598
14555244	692	708	protein kinase C	Gene	112476
14555244	710	713	PKC	Gene	112476
14555244	727	730	Bax	Gene	581
14555244	763	768	PC-12	CellLine	CVCL:0481
14555244	773	786	neuroblastoma	Disease	MESH:D009447
14555244	787	792	human	Species	9606
14555244	793	801	dopamine	Chemical	MESH:D004298
14555244	810	817	SH-SY5Y	CellLine	CVCL:0019
14555244	942	967	amyloid precursor protein	Gene	351
14555244	1011	1021	rasagiline	Chemical	MESH:C031967
14555244	1241	1253	cytochrome c	Gene	54205
14555244	1280	1289	caspase 3	Gene	836
14555244	1328	1341	cyclosporin A	Chemical	MESH:D016572
14555244	1345	1350	Bcl-2	Gene	596
14555244	1370	1377	SH-SY5Y	CellLine	CVCL:0019
14555244	1385	1395	Rasagiline	Chemical	MESH:C031967
14555244	1432	1435	PKC	Gene	112476
14555244	1552	1555	PKC	Gene	112476
14555244	1631	1640	propargyl	Chemical	-
14555244	1667	1677	rasagiline	Chemical	MESH:C031967
14555244	1688	1702	propargylamine	Chemical	MESH:C009054
14555244	1802	1816	propargylamine	Chemical	MESH:C009054
14555244	1922	1932	rasagiline	Chemical	MESH:C031967
14555244	1946	1955	Alzheimer	Disease	MESH:D000544
14555244	1973	1979	TV3326	Chemical	MESH:C423264
14555244	1984	1990	TV3279	Chemical	MESH:C476551
14555244	2026	2045	Parkinson's disease	Disease	MESH:D010300
14555244	2047	2066	Alzheimer's disease	Disease	MESH:D000544
14555244	2077	2103	neurodegenerative diseases	Disease	MESH:D019636
14555244	Negative_Correlation	MESH:C031967	54205
14555244	Negative_Correlation	MESH:C031967	MESH:D009447
14555244	Negative_Correlation	MESH:C476551	MESH:D010300
14555244	Negative_Correlation	MESH:C031967	MESH:D020258
14555244	Positive_Correlation	MESH:D018698	MESH:D020258
14555244	Positive_Correlation	MESH:D015632	MESH:D010302
14555244	Negative_Correlation	MESH:C031967	MESH:D000544
14555244	Negative_Correlation	MESH:C031967	836
14555244	Association	MESH:C031967	MESH:C032837
14555244	Negative_Correlation	MESH:C031967	MESH:D010300
14555244	Negative_Correlation	MESH:C476551	MESH:D000544
14555244	Negative_Correlation	MESH:C031967	581
14555244	Negative_Correlation	MESH:C423264	MESH:D000544
14555244	Positive_Correlation	MESH:C031967	112476
14555244	Negative_Correlation	MESH:C031967	MESH:D019636
14555244	Negative_Correlation	MESH:C423264	MESH:D019636
14555244	Negative_Correlation	MESH:D016572	836
14555244	Negative_Correlation	MESH:C031967	MESH:D018698
14555244	Negative_Correlation	MESH:C031967	MESH:D010302
14555244	Positive_Correlation	MESH:C031967	598
14555244	Negative_Correlation	MESH:C476551	MESH:D019636
14555244	Negative_Correlation	MESH:C031967	4129
14555244	Association	MESH:C031967	MESH:D015632
14555244	Negative_Correlation	MESH:C423264	MESH:D010300
14555244	Positive_Correlation	MESH:C031967	596

